5913 Results

People

  1. Ladanyi
    Ladanyi
  2. Solit
    Solit
  3. Levine
    Levine
  4. Berger
    Berger
  5. Schultz
    Schultz
  6. Arcila
    Arcila
  7. Hakimi
    Hakimi
  8. Chandarlapaty
    Chandarlapaty
  9. Zehir
    Zehir
  10. Mellinghoff
    Mellinghoff

Groups

  1. Human Oncology and Pathogenesis Program (5913)
  2. GSK Faculty (5696)
  3. Department of Medicine (4258)
  4. Department of Pathology and Laboratory Medicine (3036)
  5. Tow Center for Developmental Oncology (TCDO) (2612)
  6. Solid Tumor Oncology Division (2599)
  7. Sloan Kettering Institute Postdocs (1984)
  8. Hematologic Malignancies, Division of (1879)
  9. Center for Hematologic Malignancies (1845)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (1735)
  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (2984)
  2. Meeting Abstract (2526)
  3. Review (137)
  4. Editorial (106)
  5. Book Section (54)
  6. Research Letter (41)
  7. Guidelines (18)
  8. Correspondence (16)
  9. Miscellaneous (15)
  10. Conference Paper (13)
  11. Book Whole (3)
Groups
  1. Human Oncology and Pathogenesis Program (5913)
  2. GSK Faculty (5696)
  3. Department of Medicine (4258)
  4. Department of Pathology and Laboratory Medicine (3036)
  5. Tow Center for Developmental Oncology (TCDO) (2612)
  6. Solid Tumor Oncology Division (2599)

More Groups

People
  1. Marc Ladanyi (1326)
  2. David Solit (779)
  3. Ross Levine (774)
  4. Michael Berger (765)
  5. Nikolaus Schultz (486)
  6. Maria Arcila (426)

More People

Years
  1. 2025 (119)
  2. 2024 (359)
  3. 2023 (402)
  4. 2022 (451)
  5. 2021 (380)
  6. 2020 (457)

More Years

Publications
  1. Journal of Clinical Oncology (636)
  2. Blood (495)
  3. Cancer Research (412)
  4. Modern Pathology (299)
  5. Clinical Cancer Research (268)
  6. Laboratory Investigation (262)

More Publications

Publishers
  1. American Association for Cancer Research (871)
  2. Nature Publishing Group (757)
  3. American Society of Clinical Oncology (702)
  4. American Society of Hematology (541)
  5. Elsevier Inc. (420)
  6. Nature Research (312)

More Publishers

Results (5913)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Fludarabine-based conditioning secures engraftment of secondary hematopoietic stem cell allografts (HSCT) used to treat graft failure
    Meeting Abstract

    Chewning, J. H.; Castro-Malaspina, H. R.; Hsu, K.; Jakubowski, A. A.; Kernan, N. A.; Papadopoulos, E. B.; Perales, M. A.; Prockop, S. E.; Small, T. N.; van den Brink, M. R. M.; more...
    Biology of Blood and Marrow Transplantation (2005)

    Fulltext@MSK | Save
  • Induction of remission prior to transplantation improves the disease-free survival (DFS) of patients with advanced myelodysplastic syndromes (MDS) treated with myeloablative T-cell depleted (TCD) stem cell transplants (SCT) from HLA identical siblings
    Meeting Abstract

    Castro-Malaspina, H. R.; Jakubowski, A. A.; Papadopoulos, E. B.; Boulad, F.; Young, J. W.; Kernan, N. A.; Perales, M. A.; Small, T. N.; Hsu, K. C.; Chiu, M.; more...
    Blood (2005)

    Fulltext@MSK | Save
  • Expression profiling of-tyrosine kinase genes in synovial sarcoma reveals a highly distinct kinase repertoire and prominent overexpression of PDGFRA
    Meeting Abstract

    Barbashina, V.; Saito, T.; Shukla, N.; Chuai, S.; Olshen, A. B.; Antonescu, C. R.; Ladanyi, M.
    Modern Pathology (2005)

    Fulltext@MSK | Save
  • Expression profiling of tyrosine kinase genes in synovial sarcoma reveals a highly distinct kinase repertoire and prominent overexpression of PDGFRA
    Meeting Abstract

    Barbashina, V.; Saito, T.; Shukla, N.; Chuai, S.; Olshen, A. B.; Antonescu, C. R.; Ladanyi, M.
    Laboratory Investigation (2005)

    Fulltext@MSK | Save
  • Xp11-translocation carcinomas of the kidney as chemotherapy-induced secondary malignancies
    Meeting Abstract

    Argani, P.; Lae, M.; Ballard, E. T.; Rodriguez, M.; Hutchinson, B.; Reuter, V. E.; Ladanyi, M.
    Modern Pathology (2005)

    Fulltext@MSK | Save
  • Xp11-translocation carcinomas of the kidney as chemotherapy-induced secondary malignancies
    Meeting Abstract

    Argani, P.; Lae, M.; Ballard, E. T.; Rodriguez, M.; Hutchinson, B.; Reuter, V. E.; Ladanyi, M.
    Laboratory Investigation (2005)

    Fulltext@MSK | Save
  • Pulsatile administration of the epidermal growth factor receptor inhibitor gefitinib is significantly more effective than continuous dosing for sensitizing tumors to paclitaxel
    Journal Article

    Solit, D. B.; She, Y.; Lobo, J.; Kris, M. G.; Scher, H. I.; Rosen, N.; Sirotnak, F. M.
    Clinical Cancer Research (2005)

    Fulltext@MSK | Save
  • Persistence makes perfect: The benefits of IL-2 in adoptive immunotherapy
    Journal Article

    Rizzuto, G. A.; Wolchok, J. D.
    Cytotherapy (2005)

    Fulltext@MSK | Save
  • Distinct CD4+-T-cell responses to live and heat-inactivated Aspergillus fumigatus conidia
    Journal Article

    Rivera, A.; Van Epps, H. L.; Hohl, T. M.; Rizzuto, G.; Pamer, E. G.
    Infection and Immunity (2005)

    Fulltext@MSK | Save
  • KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib
    Journal Article

    Pao, W.; Wang, T. Y.; Riely, G. J.; Miller, V. A.; Pan, Q.; Ladanyi, M.; Zakowski, M. F.; Heelan, R. T.; Kris, M. G.; Varmus, H. E.
    PLos Medicine (2005)

    Fulltext@MSK | Save